PATENT CLAIM ANALYSIS

Application Number: 16117107
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "341000"]

Abstract:
The present invention provides compounds of Formula (I): a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, a solvate thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Claim (Index 3):
A compound according to  claim 1 , wherein:\n ring A is independently selected from phenyl substituted with 0-1 R 6  and 0-2 R 7 ; and alternatively, R 6  and R 7 , together with the carbon atoms to which they are attached, combine to form a 6-membered carbocyclic ring.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 96.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15866871', '15123773', '15602515', '15618182', '15123791']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8327852944257788
- 35 USC 102 Novelty (BERT): 0.5678230127458793
- Combined Prediction Score: 0.8062890662577888
- Mean Citation Score: 398.53599
- Max Citation Score: 441.1919
- Similarity Product: 424.46250879283537

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test